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Résumé 
Objectif: En fonction du type de chirurgie, 10 à 50 % des patients ayant une douleur 
postopératoire sont à risque de chronicisation. Le but de cette étude était de déterminer 
l’incidence de la douleur postopératoire  persistante (DPOP) et d’identifier les facteurs de 
risques après chirurgie urologique. La relation entre les paramètres périopératoires et la 
DPOP a été évaluée par analyse multivariée. 
Type d’étude : rétrospective observationnelle 
Patients : 288 patients opérés de chirurgie urologique associée à une DPOP. 
Méthodes : Les interventions urologiques associées à une DPOP ont été définies. Tous les 
patients ayant bénéficié d’une de ces interventions entre au cours de l’étude ont reçu par 
courrier un questionnaire au moins 3 mois après la chirurgie. Les dossiers de ces patients 
ont été étudiés rétrospectivement. 
Résultats: Huit % des patients avaient une douleur préopératoire. En moyenne 6 mois après 
la chirurgie, 24 % des patients déclaraient ne DPOP. Parmi eux, 36% décrivaient une 
douleur neuropathique.  Ils présentaient plus de douleur préopératoire et leur consommation 
postopératoire de morphine était augmentée. L’administration postopératoire d’AINS 
réduisait significativement la DPOP. Deux facteurs de risques indépendants de DPOP ont 
été identifiés: existence d’une douleur pré opératoire  (OR = 21.6, 95% CI 6.7-69.5, p < 
0.0001), consommation de morphine  à 48 h postopératoire supérieure à 6 mg  (OR = 2.3, 
95% CI 1.2-4.3, p = 0.0118).  
Discussion : Ces résultats confirment le rôle de la douleur préopératoire et de la 
consommation de morphiniques dans la genèse de la DPOP. La prise en charge 
périopératoire doit être ainsi individualisée. 
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Abstract 
Objective: Ten to 50 % of patients with postsurgical pain develop chronic pain depending on 
the type of surgery. The objective of this study was to assess the incidence of persistent 
postsurgical pain (PPSP) and to identify risk factors following urology surgery. Pre, intra and 
postoperative factors were assessed and their relationships wit  PPSP were evaluated using 
multivariate analysis.  
Design: retrospective observational study  
Patients: 288 patients scheduled for urology surgery. Reasons for non-inclusions: patients 
who underwent a procedure not defined as being associated with PPSP. 
Methods: Surgical urologic procedures potentially associated with PPSP were defined. All 
patients who had one of these procedures during the study period received a questionnaire 
by mail at least 3 months after the surgery. The files of these patients were retrospectively 
studied.  
Results: Eight percent of the patients had preoperative pain. PPSP, assessed approximately 
6 months after the surgery, was reported by 24 % of the patients. Twenty-five (36%) of them 
reported neuropathic pain. Patients with PPSP had significantly more preoperative pain and 
an increased postoperative morphine consumption. Postoperative NSAID administration led 
to less persistent pain. Multivariate logistic regression analysis identified two independent 
risk factors of developing persistent pain: preoperative pain (OR = 21.6, 95% CI 6.7-69.5, p < 
0.0001), morphine consumption 48 hours after surgery higher than 6 mg (OR = 2.3, 95% CI 
1.2-4.3, p = 0.0118). 
Conclusion: These findings confirm the role of preoperative pain and morphine consumption 
in the genesis of PPSP and call for establishing clinical perioperative pathways tailored to the 
patient. 
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Introduction 
Since Perkin’s review published in 2000, persistent post surgical pain (PPSP) is considered 
as an outcome of surgery (1). The last publication by the American Committee on Advancing 
Pain Research, Care and Education reported that 10 to 50 % of patients with postsurgical 
pain develop chronic pain depending on the type of surgery (2). Thereby, identifying risk 
factors for (PPSP) can provide some basis for prevention (3). Trying to prevent the 
development of PPSP should be a cornerstone of perioperative medicine (4). Preoperative 
pain, nerve injury, severity of the immediate postoperative pain, opioid consumption are 
factors associated with increased risk of PPSP (5,6). The prevalence of PPSP may also vary 
depending on the type of surgery. Indeed, 25 to 60 % of the patients reported PPSP after 
thoracotomy (7), 50 to 80 % after amputation (8), 15% after inguinal hernia repair (9), 5 to 30 
% after hysterectomy (10), 24 to 50 % after mastectomy (11) and 22 % after carpal tunnel 
surgery (12). Therefore, risk factors need to be clearly identified in different type of surgery. 
This is critical because the identified risk factors of PPSP could depend on the type of 
surgery. For example, the international guidelines for prevention and management of PPSP 
following inguinal hernia repair strongly suggest that the identification of all three nerves 
plays an important role in reducing the risk of PPSP (13). The absence of such 
recommendations after urology surgery is probably due to the lack of data. 
Therefore, our objective was to assess the incidence of PPSP, its characteristics (i.e 
neuropathic pain) and the its associated risk factors following urology surgery. We assessed 
pre, intra and postoperative factors and evaluated their relationship with PPSP. 
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Methods 
Patients  
This observational cohort study included all consecutive patients undergoing surgical 
urologic procedure in our university hospital between May 2009 and August 2010. Surgical 
procedures were classified into three categories according to the risk of PPSP. This risk 
stratification took into account surgery duration, the degree of invasiveness, and the surgery 
associated risk of postoperative pain and postoperative complications. The three categories 
were as follows: low (hernia, orchidectomy), intermediate (laparoscopic prostatectomy / 
complete nephrectomy / adrenalectomy) and high (pelvectomy, prostatocystetomy, 
cystectomy, open prostatectomy, open nephrectomy and partial nephrectomy). All patients 
received a questionnaire by mail at least 3 months after surgery (Appendix 1). This 
questionnaire was mailed only once. Patients who did not answer after 2 months were 
considered as being lost. The files of these patients were also retrospectively studied. The 
local ethics committee waived informed consent as it was a non-interventional study (number 
12-25, on 12 march 2012). 
 
Data collection 
The following data were recorded: age, sex, type of surgery, type of anesthesia, pain 
preexisting the surgery, pre-, intra- and postoperative pain medication, morphine 
consumption 48 hours after the surgery, time between surgery and questionnaire 
administration. At the time of the questionnaire, the type of pain, the pain score (numerical 
rating scale from 0 to 10, where 0 = no pain and 10 = worst pain imaginable), and the use of 
pain medication were also collected. Neuropathic pain was defined using the DN4 “7 items” 
score (14). A DN4 score higher than 3 (on 7 items) was considered as positive for 
neuropathic pain. Pain preexisting the surgery was defined as pain of any type associated or 
not with the condition requiring surgery. In addition to the 7 items, the effect of “brushing”, 
which is part of the original complete DN4 questionnaire (10 items), was included as an 8th 
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item. 
PPSP was considered present when the patient reported pain with a NRS of 3 or higher, in 
the area of the surgery. 
 
Statistical analysis 
Statistical analysis was performed with SAS software 8.02 (SAS Institute, Cary, N.C., USA). 
The normality of the variables was checked using a Shapiro-Wilk test. For continuous 
variables the mean (SD) is reported unless noted otherwise, and for categorical variables the 
number of patients in each category and the corresponding percentage are given. The 
characteristics of patients who developed PPSP and those who did not were compared using 
Student’s t test or Wilcoxon rank sum test when appropriate for continuous variables, and the 
χ2 or Fisher’s exact test when appropriate for categorical variables. To identify risk factors 
independently associated with the occurrence of PPSP, variables found to be significantly 
different (p < 0.05) between the two groups were entered into a forward stepwise logistic-
regression model. All patients were entered in this model (no missing data). Each variable 
used in this logistic regression analysis was binary; therefore continuous variables were 
recoded using the median value of the distribution in the absence of a clinically defined cutoff 
point. All p values are two-sided and for all analysis, a p value < 0.05 was considered 
significant. 
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Results  
During the study period 523 patients were scheduled for one of the surgical procedures 
included in the 3 predefined categories. Amongst them 288 (55%) answered the 
questionnaire. Mean time from surgery to questionnaire response was 201 ± 53 days. Mean 
age was 64 ± 12 years. Three quarters of the patients were male. The majority of the 
patients underwent a procedure classified as intermediate (87 % vs high risk: 5% and low 
risk: 8%). The vast majority of the patients had a general anesthesia (table 1). Two patients 
(0,69 %) had a regional anesthesia (a TAP block) (Table 1).  According to the institution 
protocol: the steroid administered was dexamethasone 8 mg peroperatively. If the patients 
had steroids before surgery, the prescription was continued; the NSAID administered was 
ketoprofen 50 mg every 6 hours; nefopam was administered every 6 hours (20 mg), 
paracetamol was systematically prescribed in all the patients (1g every 6 hours); lidocaine 
was administered preoperatively only (1,5 mg.kg.h-1); ketamine was administered at the 
dosage recommended (bolus 0,25 mg.kg-1 and then 0,2 mg.kg.h-1 continuously) (15). 
Less than 8 % (n = 22) of the patients had preoperative pain. PPSP, assessed approximately 
from 3 to 11 months after the surgery, was reported by 24 % (n = 70) of the patients.  
Very few patients answered the 8th item of the questionnaire. This did not allow any statistics. 
Patients with PPSP  
Among the 70 (24 %) patients describing PPSP, 30 (43 %) had sleep disturbance and 34 (49 
%) used pain medication (Table 1). Twenty-five (36%) of them reported neuropathic pain 
(DN4 ≥3). The worst pain experienced within the week prior the questionnaire was higher 
than 5 on a 10-point scale in 28 (40 %) patients with PPSP.  
 
Predictive factors of PPSP in univariate analysis 
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Preoperative pain, and postoperative morphine consumption were significantly associated 
with an increased risk of PPSP, whereas patients who received postoperative nonsteroidal 
anti-inflammatory drugs reported significantly less PPSP (Table 2). The global mean 
morphine consumption 48 hours after surgery was 13 ± 19 mg. In patients without PPSP, it 
was 10 ± 15 mg and this consumption doubled in patients reporting PPSP (22 ± 26 mg). The 
patients who received a preperitoneal continuous infiltration significantly undergone more 
procedures classified as high risk and their consumption of postoperative morphine was 
significantly higher (p = 0.016).  
 
Predictive factors of PPSP in multivariate analysis 
 
Multivariate logistic regression analysis identified two independent risk factors of developing 
PPSP: preoperative pain (OR = 21.6, 95% CI 6.7-69.5, p < 0.0001) and morphine 
consumption 48 hours after surgery higher than 6 mg (OR = 2.3, 95% CI 1.2-4.3, p = 0.012).  
 
Discussion 
In this study, 24% of the patients reported PPSP after urology surgery. Amongst them, 36 % 
reported neuropathic pain. The two independent risk factors associated with PPSP following 
urology surgery were:  preoperative pain and postoperative morphine consumption.  
The prevalence of PPSP of 24% 3 to 11 months after urology surgery is comparable with 
other studies. Recently published incidences vary between 14% 3 months after 
prostatectomy (16) and 26 to 28% 3 months after nephrectomy (17,18). In most previous 
studies the distinction between neuropathic and nociceptive pain was not described. The 
recent Tromso study reported an incidence of 24.5 % of sensory abnormalities after various 
type of surgery. This was strongly associated with PPSP (19).  In our study, PPSP was 
classified as neuropathic pain in 36 % of the cases. This is higher than the 14 % of 
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neuropathic PPSP after nephrectomy reported by Owen et al (17). However, our results were 
not specifically focused on nephrectomy but on various urological surgeries. 
Preoperative pain was the strongest independent risk factor with an odds ratio of 21.6 (95% 
CI 6.7-69.5). Recent reviews have described preoperative pain as being a typical risk factor 
of PPSP (4). Some studies have indeed reported a link between preoperative pain and PPSP 
after amputation (20), hernia repair (21), hysterectomy (10,22) and thoracotomy (23). Some 
studies did not report a statistically significant link especially after thoracotomy (7). Indeed, 
the authors of a systematic review published in 2009 were not able to draw a conclusion 
because of the inconsistencies of the data (24). These discrepancies could be due to 
interindividual variability described by some authors (25). Our results showed a strong link 
and add more data into this field. The likelihood of PPSP in patients with preoperative pain 
was so high in our study that it called for establishing specific clinical perioperative pathways 
in these patients. 
In our study, morphine consumption higher than 6 mg 48 hours after the surgery was also 
associated with an increased risk of PPSP. Opioid-induced hyperalgesia had been first 
described with remifentanil (26). Since this article, it has also been identified with fentanyl 
and with morphine. Chronic use of opioid can also increase the risk of hyperalgesia (27). 
Within the perioperative context, a study showed that opioid-induced hyperalgesia with a 
high dose of remifentanil was associated with a higher incidence of PPSP after thoracotomy 
(28). Preventing hyperalgesia (inflammation-induced and opioid-induced hyperalgesia) can 
prevent post surgical pain 6 months to one year after surgery (29). This was shown with 
ketamine or epidural (29,30). Overall, it seems that preventing high opioid consumption 
would prevent opioid-induced hyperalgesia and PPSP. However, high postoperative 
morphine consumption is always associated with intense acute postoperative pain. Indeed, 
acute postoperative pain per se has also been linked with the risk of PPSP (31) even in 
patients who did not receive any morphine (12).  The need for additional clinical studies on 
surgical-induced and opioid-induced hyperalgesia was recently underlined (32).  Therefore 
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our study brings more evidence in confirming the hypothesis that opioid consumption 
including postoperative morphine consumption is linked to the risk of PPSP.  
No other data were significantly associated with the risk of PPSP in our study. In particular, 
perioperative administrations of ketamine, gabapentine or pregabaline were not protective 
against PPSP. Only a very small fraction of the patients received gabapentinoids. However, 
the most recent meta analysis on the subject did not suggest any reduction in chronic pain 
with gabapentinoids (33). Ketamine was often administered (57%) in our study but the 
administration was only very rarely continued after the end of surgery. The most recent meta 
analysis reported that ketamine could reduce PPSP 3 months after surgery if the 
administration was prolonged for 24 hours (33). This could explain our negative results.  
Our study has several limitations. It is an observational study that did not include the 
elements of the ideal study design of PPSP as defined by Kehlet et al. (34).  The minimum of 
three months period was chosen according to the literature. Although the IASP-published 
definition several years ago was 2 months (35), some authors have proposed 3 months (34). 
In our study, the mean time between surgery and completing the questionnaire was 201 days 
with a wide range (92-336). However, this elapsed survey period was statistically similar 
between the two groups. Our study was neither randomized nor controlled and the patients 
who received a local anesthetics infiltration significantly undergone more procedures 
classified as high risk and their consumption of postoperative morphine was significantly 
higher.  This was not the case for ketamine or gabapentinoids administration. Finally, we did 
not record the preoperative morphine consumption, which could influence the postoperative 
consumption.  
 
In conclusion, our study confirmed that preoperative pain and morphine consumption are 
strong risk factors of PPSP after urology surgery. These findings bring evidences in the role 
of preoperative pain and morphine consumption in the genesis of PPSP and could suggest 
the need to establish clinical perioperative pathways tailored to the patient. 
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Legends 
Table 1: Demographics of the studied population 
Age, years: mean, (SD, range) 64 (12, 16–87) 
 
Sex F/M (%) 25/75 
 
Preoperative pain, n (%) 22 (8) 
 
Type of surgery, n (%) 
 Laparoscopic/open nephrectomy 59 (20)/27 (9) 
 Laparoscopic/open prostatectomy 78(27)/3 (1) 
 Adenomectomy 34 (12) 
 Cystectomy 2 (0.7) 
 Prostatocystectomy 13 (4.5) 
 Laparoscopic/open surrenalectomy 10 (3.5)/1 (0.3) 
 Hernia 2 (0.7) 
 Orchidectomy 7 (2.4) 
 Renal transplant 38 (13) 
 Pelvectomy 8 (3) 
 Laparoscopic promontofixation 6 (2) 
 
High risk surgery, n (%) 23 (8) 
 
Intermediate risk surgery 250 (87) 
 
Low risk surgery 15 (5) 
 
General/spinal anesthesia, n (%) 280 (97)/8 (3) 
 
Preoperative, n (%) 
 Gabapentin, pregabalin 7 (2.4) 
 
Dose of peroperative sufentanil per hour (microg): mean (SD) 14 (23) 
 
Dose of peroperative remifentanil per hour (μg): mean (SD) 47 (154) 
 
Peroperative, n (%) 
 Steroids 68 (24) 
 NSAID 100 (35) 
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 Ketamine 165 (57) 
 Nefopam 178 (62) 
 Lidocaine 3 (1) 
 
Postoperative, n (%) 
 Steroids 47 (16) 
 NSAID 91 (32) 
 Ketamine 5 (2) 
 Nefopam 236 (82) 
 Regional anesthesia (TAP block) 2 (1) 
 LA continuous infiltration 40 (14) 
 
Morphine consumption at h48 (mg): mean (SD) 13 (19) 
 
Patients with persistent pain (> 3 months), n (%) 70 (24) 
 
 
Table 2: Characteristics of the patients with persistent pain  
Actual pain, mean (SD) 3.57 (1.53) 
Mildest pain per week, mean (SD) 1.77 (1.84) 
Worst pain per week, mean (SD) 4.44 (2.28) 
Worst pain per week > 5/10, n (%) 28 (40) 
Worst pain per week > 7/10, n (%) 12 (17) 
Neuropathic pain (DN4 ≥ 3), n (%) 25 (36) 
Sleep disturbance, n (%) 30 (43) 
Use of pain medication, n (%) 34 (49) 
 
Table 3: Comparison between patients with and without persistent pain: NSAID: non 
steroidal anti-inflammatory drugs 
 
Patients with 
persistent pain 
(n = 70) 
Patients without 
persistent pain 
(n = 218) 
P 
Age > 65 years, n (%) 29 (41) 118 (54) 0.064 
 
Sex F (%) 29 24 0.427 
 
Time from surgery to 
questionnaire response (mean, 
202 (55) 201 (53) 0.8473 
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Patients with 
persistent pain 
(n = 70) 
Patients without 
persistent pain 
(n = 218) 
P 
SD) 
 
Preoperative pain, n (%) 18 (26) 4 (2) < 0.0001 
 
General anesthesia, n (%) 69 (99) 211 (97) 0.684 
 
High risk surgery, n (%) 6 (8.6) 17 (8) 0.261 
 
Intermediate risk surgery 63 (90) 187 (86)  
 
Low risk surgery 1 (1.4) 14 (6)  
 
Preoperative, n (%) 
 Gabapentin, pregabalin 2 (3) 5 (2) 1.000 
 
Dose of peroperative sufentanil 
per hour (μg) (mean, SD) 
12 (7) 14 (27) 0.774 
 
Dose of peroperative 
remifentanil per hour (μg) 
(mean, SD) 
54 (175) 45 (146) 0.905 
 
Peroperative, n (%) 
 Steroids 20 (29) 48 (22) 0.261 
 NSAID 19 (27) 81 (37) 0.125 
 Ketamine 39 (56) 126 (58) 0.759 
 Nefopam 42 (60) 136 (62) 0.721 
 Lidocaine 0 3 (1) 1.000 
 
Postoperative, n (%) 
 Steroids 14 (20) 33 (15) 0.338 
 NSAID 15 (21) 76 (35) 0.035 
 Ketamine 1 (1) 4 (2) 1.000 
 Nefopam 59 (84) 177 (81) 0.558 
 Regional anesthesia (TAP 
block) 
0 2 (1) 1.000 
 LA continuous infiltration 18 (26) 22 (10) 0.001 
 
Morphine consumption at h48 23 (26) 10 (15) 0.0002 
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Patients with 
persistent pain 
(n = 70) 
Patients without 
persistent pain 
(n = 218) 
P 
(mg): mean (SD) 
NSAID: non-steroidal anti-inflammatory drugs. 
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